BETA
Minneapolis-based medical device company offering suture anchors, interference screws and fixation systems for sports medicine and soft-tissue repair.
Responsive Arthroscopy develops and markets implants and instruments for orthopedic sports medicine. Its published portfolio covers procedures involving the shoulder, knee, hip, foot and ankle, including soft-tissue fixation, ligament reconstruction and syndesmosis repair.
The company’s FDA history includes interference-screw, suture-anchor and Thunderbolt fixation systems, with records under both Responsive Arthroscopy, LLC and Responsive Arthroscopy, Inc. Individual authorizations and current commercial availability are distinguished in the product and regulatory section.
Johnson & Johnson MedTech announced an exclusive U.S. commercial distribution agreement with Responsive Arthroscopy on November 14, 2024, describing a focus on sports soft-tissue repair solutions. The announcement does not specify every covered product or establish the current terms of the agreement.
Responsive Arthroscopy’s reviewed FDA history contains 13 510(k) clearances under its LLC and Inc. names. Eight decisions are mapped to the selected commercially advertised screw, suture-anchor, wedge-anchor and Thunderbolt families shown below. The remaining five cover Mustang, Stealth/Mini Stealth, Shadow, Osprey and Mini Superhawk; their current commercial availability and exact mapping to the advertised portfolio were not established, so they are excluded from the snapshot totals. [13][14][15][16][17][18][19][20][21][22][23][24][25]
The latest matched decision is K261632 for Thunderbolt, dated July 20, 2026. Clearances apply to the configurations and indications in each FDA document; an earlier product photograph does not establish availability of every subsequently cleared configuration. No matching De Novo grants, original PMAs or FDA recall events were identified within the company, product-name and linked-identifier searches performed. [25][27][26][28]
Latest recorded source review: 2026-10-22.
Documented commercial product families.
PEEK and titanium interference screws for tissue fixation in ligament reconstruction. The image shows the PEEK configuration. [6][8][13][18]
FDA-clearedCommercially advertised by the manufacturer; exact models and market availability should be confirmed.
Selected PEEK soft-tissue fixation systems presented on the company’s shoulder page include Valor, Hornet, Super Hornet, Falcon and Lightning. The image shows Valor anchors and inserters. [7][10][14][17]
FDA-clearedCommercially advertised by the manufacturer; exact models and market availability should be confirmed.
Knotless PEEK wedge-anchor systems for soft-tissue fixation, with shoulder and hip configurations documented by the manufacturer. [7][5][9][15][16]
FDA-clearedCommercially advertised by the manufacturer; exact models and market availability should be confirmed.
Suture-button fixation system offered for syndesmosis repair, with an optional two-hole plate. FDA records also describe additional labeled soft-tissue fixation applications. The image shows the manufacturer’s published earlier configuration. [4][11][19][25]
FDA-clearedCommercially advertised by the manufacturer; exact models and market availability should be confirmed.
Adjustable suture-anchor system advertised for lateral ankle stabilization and Brostrom repair. This is the manufacturer’s Superhawk system, distinct from the separately cleared Mini Superhawk. [4][12]
Marketed · authorization mapping not establishedCommercially advertised by the manufacturer; exact models and market availability should be confirmed.
Publicly documented relationships; coverage may be incomplete.
| Partner | Territory / scope | Products |
|---|---|---|
| Johnson & Johnson MedTech [29] | United States · agreement announced November 2024 | Sports soft-tissue repair solutions; exact covered product families not specified |
Sources checked October 22, 2026.
FDA issued a substantially equivalent decision for the Thunderbolt System under K261632. Clearance does not establish launch timing for every cleared configuration. [25]
Johnson & Johnson MedTech announced an exclusive U.S. commercial distribution agreement for sports soft-tissue repair solutions. Exact product scope and continuing contractual terms are not independently confirmed. [29]
Accessed 10/22/2026